Intellectual Property India Publishes Patent Application for 'Use Of Cyclodextrins As Radiostabilisers' Filed by Ge Healthcare Limited

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202518047327 A) filed by Ge Healthcare Limited, Buckinghamshire, U.K., on May 16, for 'use of cyclodextrins as radiostabilisers.'

Inventor(s) include Wikene, Kristine; Khan, Imtiaz Ahmed; and Mcrobbie, Graeme.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides a radiopharmaceutical composition comprising the following four components: (i) a radio-labelled compound; (ii) ethanol; (iii) a stabilizer of the radio-labelled compound; and (iv) a cyclodextrin. The present invention also provides a radiopharmaceutical composition comprising: (i) a radio-labelled compound; (ii) a stabilizer of the radio-labelled compound, wherein the stabilizer comprises: ascorbic acid, aspartic acid, cysteine, maleic acid, gentisic acid, glutathione, glutamic acid, mannitol, nicotinamide, calcium chloride, N-t-butyl-alphaphenylnitrone (PBN), tartaric acid, para-aminobenzoic acid (pABA), chloride ions or salts or combinations thereof; and (iii) a cyclodextrin."

The patent application was internationally filed on Oct. 21, 2020, under International application No.PCT/EP2020/079659.

Disclaimer: Curated by HT Syndication.